切换至 "中华医学电子期刊资源库"

中华肩肘外科电子杂志 ›› 2018, Vol. 06 ›› Issue (01) : 54 -58. doi: 10.3877/cma.j.issn.2095-5790.2018.01.009

所属专题: 文献

论著

肩肘外科手术后并发上消化道出血的临床分析
张媛媛1, 刘心怡1, 张黎明1, 吴芸1, 刘玉兰1,()   
  1. 1. 100044 北京大学人民医院消化科
  • 收稿日期:2017-07-16 出版日期:2018-02-05
  • 通信作者: 刘玉兰

Clinical analysis of postoperative upper gastrointestinal bleeding (UGIB) after shoulder and elbow surgery

Yuanyuan Zhang1, Xinyi Liu1, Liming Zhang1, Yun Wu1, Yulan Liu1,()   

  1. 1. Department of Gastroenterology, Peking University People's Hospital, Beijing 100044, China
  • Received:2017-07-16 Published:2018-02-05
  • Corresponding author: Yulan Liu
  • About author:
    Corresponding author: Liu Yulan, Email:
引用本文:

张媛媛, 刘心怡, 张黎明, 吴芸, 刘玉兰. 肩肘外科手术后并发上消化道出血的临床分析[J]. 中华肩肘外科电子杂志, 2018, 06(01): 54-58.

Yuanyuan Zhang, Xinyi Liu, Liming Zhang, Yun Wu, Yulan Liu. Clinical analysis of postoperative upper gastrointestinal bleeding (UGIB) after shoulder and elbow surgery[J]. Chinese Journal of Shoulder and Elbow(Electronic Edition), 2018, 06(01): 54-58.

目的

分析肩肘外科手术后并发上消化道出血的临床特点,并分析其危险因素。

方法

回顾性分析2007年1月至2015年12月于北京大学人民医院行肩肘外科手术治疗后并发上消化道出血患者的临床资料,总结其临床特点,分析引起上消化道出血的危险因素。

结果

肩肘外科术后发生上消化道出血共33例,发生率为3.36%(33/983);单因素分析显示高龄、性别、手术时间长、吸烟史、饮酒史、消化性溃疡或出血史、应用抗凝药物或抗血小板药物等因素与肩肘外科手术患者术后发生上消化道出血明显相关(P <0.05);非条件多因素Logistic分析结果显示高龄、性别、手术时间长、消化性溃疡或出血史、应用抗凝药物或抗血小板药物是肩肘外科手术患者术后发生上消化道出血的独立危险因素(P <0.05)。

结论

肩肘外科手术患者术后发生上消化道出血较为少见,高龄、性别、手术时间长、消化性溃疡或出血史、应用抗凝药物或抗血小板药物是肩肘外科手术患者术后发生上消化道出血的独立危险因素。

Background

Upper gastrointestinal bleeding (UGIB) is one of the serious complications after major orthopedic operation, which is mainly caused by stress-related ulcer (SU) . While showing no symptom in mild cases, UGIB can affect the rehabilitation and life of patients in critical cases. The symptoms of UGIB are usually hard to be detected during the early postoperative stage, which brings some difficulties to the diagnosis and treatment. Usually, more cases of UGIB are reported after major orthopedic surgery. Shoulder and elbow surgery is in rapid development recently, and most of them are small and medium surgeries including internal fixation of peripheral shoulder and elbow fractures, ligament injuries of peripheral shoulder and elbow, repair and reconstruction of rotator cuff injury, shoulder and elbow arthroplasties, etc. Thus, the postoperative UGIB is seldomly reported in these cases. Clinically, the application of prophylactic drug on every patient with shoulder and elbow surgery in avoiding digestive tract bleeding will cause unnecessary medical waste. This study retrospectively analyzed the clinical data of shoulder and elbow surgery in our hospital for nearly 8 years and collected the high-risk factors of postoperative UGIB to better grasp the clinical data of UGIB after shoulder and elbow surgery, prevent postoperative UGIB, and optimize the guideline of clinical individualized treatment.

Methods

(1) Research object. From January 1, 2007 to December 12, 2015, the information of patients with shoulder and elbow surgery under the department of orthopedics and traumatology was collected, and the patients with UGIB were included in this study. Inclusive and exclusive criteria: within one week after operation, the patients had situations including hematemesis, melena and positive occult test. The bleeding of mouth, nasopharynx and biliary tract as well as preoperative active peptic ulcer and gastrointestinal bleeding should be excluded. (2) Research methods. The general and clinical data of patients were statistically analyzed. The general data includes demographic characteristics and lifestyle habits such as age, gender, smoking, drinking, etc. The clinical data includes causes of shoulder and elbow surgery, operation time, operation method, anesthesia, gastrointestinal clinical manifestations, UGIB diagnosis, clinical outcomes, laboratory results, history of peptic ulcer and hemorrhage, anticoagulant or antiplatelet drug history, etc. The risk factors for UGIB were analyzed by single-factor analysis and multiple-factor analysis. (3) Statistical analysis. SPSS 19.0 software was used for statistical analysis. The enumeration data was analyzed by Chi-square test, and the multiple-factor analysis was performed by Logistic regression analysis. A P value < 0.05 was regarded as statistically significant.

Results

(1) General information and clinical data. A total of 33 patients developed UGIB after shoulder and elbow surgery, including 17 males (51.56%) and 16 females (48.44%) . The incidence rate was 3.36% (33/983) , and the average age was (67.609±13.948) years old. The operations that involved UGIB included shoulder and elbow arthroplasty, shoulder and elbow internal fixation, ligament repair and reconstruction, and open reduction and internal fixation of humeral shaft fracture. The average operation time was (131.00±93.36) mins. Gastrointestinal symptoms include hematemesis or vomiting coffee ground vomitus, melena or dark red colored bloody stool, abdominal pain or discomfort, nausea, etc. All the patients included in this study had positive fecal occult blood. A total of 27 cases (81.82%) underwent gastroscopy: 25 cases of gastric mucosal erosion and ulcer were diagnosed as SU (8 cases of which had active bleeding) ; 1 case had esophageal and gastric varices bleeding (the patient suffered from hepatitis B virus-related cirrhosis) ; 1 case had anastomotic ulcer after subtotal gastrectomy. Among the patients who received gastroscopy, 8 out of 23 patients who underwent rapid urease test for detection of Helicobacter pylori were positive. Based on clinical manifestations and the endoscopic diagnosis of upper gastrointestinal bleeding, there were 31 cases of SU, 1 case of esophageal and gastric varices bleeding, and 1 case of anastomotic ulcer after subtotal gastrectomy. All patients with UGIB were treated with proton pump inhibitors (PPI) , and 11 cases were treated with blood transfusion. 31 patients were discharged, and 2 patients died. One case died of UGIB, and the other died of respiratory failure caused by severe pulmonary infection. (2) Single-factor analysis of UGIB after shoulder and elbow surgery. Single-factor analysis was conducted on gender, age, international normalized ratio (INR) , platelet count, operation time, operation method, anesthesia, drinking history, smoking history, peptic ulcer or gastrointestinal bleeding history, anticoagulant or antiplatelet drug application, etc. The results showed that the risk factors of UGIB after shoulder and elbow surgery included male, advanced age, long time operation, smoking history, drinking history, peptic ulcer or gastrointestinal bleeding history, anticoagulant or antiplatelet drug usage, etc. (P <0.05) . (3) Non-conditional multiple-factor Logistic analysis of UGIB after shoulder and elbow surgery. The factors were taken as independent variable for non-conditional multiple-factor Logistic analysis. The results showed that male, advanced age, long operation time, previous history of peptic ulcer or gastrointestinal bleeding and application of anticoagulant or antiplatelet drug were the independent risk factors of UGIB after shoulder and elbow surgery (P <0.05) .

Conclusions

UGIB in patients with shoulder and elbow surgery is relatively uncommon. Advanced age, male, long operation time, history of peptic ulcer or gastrointestinal bleeding, usage of anticoagulant or antiplatelet drug are the independent risk factors of UGIB after shoulder and elbow surgery.

表1 肩肘外科手术后发生UGIB的单因素分析
表2 肩肘外科手术后发生UGIB的非条件性多因素Logistic分析
[1]
Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding[J]. N Engl J Med, 2013, 368(1): 11-21.
[2]
Eastwood GM, Litton E, Bellomo R, et al. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units[J]. Crit Care Resusc, 2014, 16(3): 170-174.
[3]
Bardou MP, Barkun A. Stress-related mucosal disease in the critically ill patient[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(2): 98-107.
[4]
张建伟,王成锋,白晓枫, 等. 胰十二指肠切除术后应激性溃疡出血的危险因素分析[J]. 中华肿瘤杂志,2010,32(1):40-43.
[5]
孙勇,曾学良,廖国庆, 等. 直肠癌患者术后发生应激性溃疡出血的影响因素分析[J]. 中国现代手术学杂志, 2012, 16(5):342-344.
[6]
Reintam Blaser A, Poeze M, Malbrain ML, et al. Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study[J]. Intensive Care Med, 2013, 39(5): 899-909.
[7]
Madhusudhan TR, Gregg PJ. Gastric protection and gastrointestinal bleeding with aspirin thromboprophylaxis in hip and knee joint replacements[J]. Ann R Coll Surg Engl, 2008, 90(4): 332-335.
[8]
中华医学会外科学分会.应激性黏膜病变预防与治疗——中国普通外科专家共识(2015) [J]. 中国实用外科杂志, 2015, 35(7): 728-730.
[9]
Frandah, W. Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit[J]. J Intensive Care Med, 2014, 29(2): 96-103.
[10]
Barletta JF, Kanji S, Maclaren R, et al. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada[J]. J Crit Care, 2014, 29(6): 955-960.
[11]
Buendgens L, Bruensing J, Matthes M, et al. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea[J]. J Crit Care, 2014, 29(4): e11-e15.
[12]
Freedberg DE, Abrams JA. Does confounding explain the association between PPIs and clostridium difficile related diarrhea?[J]. Am J Gastroenterol, 2013, 108(2): 278-279.
[13]
Lin XH, Young SH, Luo JC,et al. Risk factors for upper gastrointestinal bleeding in patients taking selective COX-2 inhibitors: a nationwide population-based cohort study[J]. Pain Med, 2017. [Epub ahead of print]
[14]
Maclaren R, Campbell J. Cost-Effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients[J]. Crit Care Med, 2014, 42(4): 809-815.
[15]
Barletta JF, Sclar DA. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic Consequences[J]. Pharmacoeconomics, 2014, 32(1): 5-13.
[16]
Lu Y, Loffroy R, Lau J, et al. Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding[J]. Br J Surge, 2014, 101(1): E34-E50.
[17]
Hebert PC, Carson JL. Transfusion threshold of 7 g per deciliter --the new normal[J]. N Engl J Med, 2014, 371(15): 1459-1461.
[1] 贾杰, 王阳, 车凯薇, 高俊峰, 王聪, 李泽阳, 梁虎. 梭形针线扣技术与Krackow缝合法对跟腱止点或近止点断裂跟腱功能恢复的疗效比较[J]. 中华损伤与修复杂志(电子版), 2024, 19(04): 307-313.
[2] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[3] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[4] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[5] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[6] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[7] 向辉, 贾晓斌, 全卫涛. 真空辅助乳腺微创旋切术治疗乳腺纤维瘤的效果及并发症观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 528-530.
[8] 王维花, 王楠, 乔庆, 罗红. 完全腹腔镜右半结肠癌切除术两种腔内消化道重建方案对比研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 574-577.
[9] 李康虎, 王继伟, 王光远. 腹腔镜下腹股沟疝修补术后并发症及防治进展[J]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 369-375.
[10] 周劲鸿, 王鉴杰, 谢肖俊. 腹腔镜经腹腹膜前疝修补术后尿潴留发生率及危险因素分析[J]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 390-395.
[11] 李澄清, 郭文毅, 王磊. 腹腔镜保留脾脏胰体尾切除术:微创胰腺外科的合理决策[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 620-624.
[12] 罗柳平, 吴萌萌, 陈欣磊, 林科灿. 胰腺全系膜切除在胰头癌根治术中的应用价值[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 651-656.
[13] 韩青雷, 丛赟, 李佳隆, 邵英梅. 术前减黄方式对壶腹周围癌胰十二指肠切除术后并发症的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 665-669.
[14] 于泽, 隋宇航, 孙备. 坏死性胰腺炎相关并发症外科干预策略[J]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 450-455.
[15] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
阅读次数
全文


摘要